Regulatory mechanisms that determine the development and function of plasma cells

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 205-230

  Calame, Kathryn L ^a   Lin, Kuo I ^a   Tunyaplin, Chainarong ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

Bcl 6; Blimp 1; IRF4; Pax5; XBP 1

Indexed keywords

ANTIGEN; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B LYMPHOCYTE RECEPTOR; CHEMOKINE RECEPTOR CXCR5; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; ISOTOPE; PROTEIN; PROTEIN BCL 6; PROTEIN IRF 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX 5; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR-4; MEMBRANE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PAX5 PROTEIN, HUMAN; PAX5 PROTEIN, MOUSE; PRDM1 PROTEIN, HUMAN; PRDM1 PROTEIN, MOUSE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PAX5; X BOX BINDING PROTEIN (RF X); X BOX BINDING PROTEIN (RF-X);

B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; DOWN REGULATION; GENE MUTATION; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MEMORY CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; ANIMAL; ANTIBODY PRODUCTION; CELL DIVISION; CYTOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; ANTIBODY FORMATION; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; GERMINAL CENTER; HUMANS; INTERFERON REGULATORY FACTORS; MEMBRANE PROTEINS; MICE; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PLASMA CELLS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0042470566     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141138     Document Type: Review

References (198)

1. Eisen HN, Simms ES, Potter M. 1968. Mouse myeloma protein with anti-hapten antibody activity: the protein produced by plasma cell tumor MOPC-315. Biochemistry 7:4126-34
2. Hozumi N, Tonegawa S. 1976. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc. Natl. Acad. Sci. USA 73:3628-32
3. Early PW, Davis MM, Kaback DB, Davidson N, Hood L. 1979. Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc. Natl. Acad. Sci. USA 76:857-61
4. Fearon DT, Carroll MC. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393-422
5. Freitas AA, Rocha B. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18:83-111
6. Hardy RR, Hayakawa K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621
7. Townsend SE, Weintraub BC, Goodnow CC. 1999. Growing up on the streets: why B-cell development differs from T-cell development. Immunol. Today 20:217-20
8. Nemazee D. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:19-51
9. Heyman B. 2000. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18:709-37
10. Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D, Harousseau JL, Bataille R, Pellat-Deceunynck C. 1999. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94:701-12
11. Lin KI, Lin Y, Calame K. 2000. Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol. Cell. Biol. 20:8684-95
12. Morse L, Chen D, Franklin D, Xiong Y, Chen-Kiang S. 1997. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity 6:47-56
13. Smith KG, Hewitson TD, Nossal GJ, Tarlinton DM. 1996. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 26:444-48
14. Slifka MK, Antia R, Whitmire JK, Ahmed R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-72
15. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813-21
16. Tomayko MM, Cancro MP. 1998. Long-lived B cells are distinguished by elevated expression of Al. J. Immunol. 160:107-11
17. Chen C, Edelstein LC, Gelinas C. 2000. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20:2687-95
18. Grumont RJ, Rourke IJ, Gerondakis S. 1999. Rel-dependent induction of Al transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400-11
19. Kuss AW, Knodel M, Berberich-Siebelt F, Lindemann D, Schimpl A, Berberich I. 1999. Al expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur. J. Immunol. 29:3077-88
20. Knodel M, Kuss AW, Lindemann D, Berberich I, Schimpl A. 1999. Reversal of Blimp-1-mediated apoptosis by Al, a member of the Bcl-2 family. Eur. J. Immunol. 29:2988-98
21. Shaffer AL, Lin K-I, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 7:51-62
22. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487-94
23. Merville P, Dechanet J, Desmouliere A, Durand L, de Bouteiller O, Garrone P, Banchereau J, Liu YJ. 1996. Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:227-36
24. Angelin-Duclos C, Cattoretti G, Lin KI, Calame K. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with blimp-1 expression in vivo. J. Immunol. 165:5462-71
25. Chen-Bettecken U, Wecker E, Schimpl A. 1987. Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells. Immunobiology 174:162-76
26. Jack HM, Wabl M. 1988. Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J. 7:1041-46
27. Galli G, Guise JW, McDevitt MA, Tucker PW, Nevins JR. 1987. Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development. Genes Dev. 1:471-81
28. Takagaki Y, Seipelt RL, Peterson ML, Manley JL. 1996. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87:941-52
29. Takagaki Y, Manley JL. 2000. Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol. Cell. Biol. 20:1515-25
30. Takagaki Y, Manley JL. 1998. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol. Cell 2:761-71
31. Martincic K, Campbell R, Edwalds-Gilbert G, Souan L, Lotze MT, Milcarek C. 1998. Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition. Proc. Natl. Acad. Sci. USA 95:11095-100
32. Phillips C, Jung S, Gunderson SL. 2001. Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA. EMBO J. 20:6443-52
33. Melchers F. 1971. Biosynthesis, transport and secretion of immunoglobulin in plasma cells. Histochem. J. 3:389-97
34. Geuze HJ, Slot JW. 1980. The subcellular localization of immunoglobulin in mouse plasma cells, as studied with immunoferritin cytochemistry on ultrathin frozen sections. Am. J. Anat. 158:161-69
35. Curtis SK, Propp R, Cowden RR, Tartaglia AP. 1975. Ultrastructure of a human malignant IgA-producing plasmacytoma. Exp. Mol. Pathol. 22:386-99
36. Wiest DL, Burkhardt JK, Hester S, Hortsch M, Meyer DI, Argon Y. 1990. Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately. J. Cell Biol. 110:1501-11
37. Morris JA, Dorner AJ, Edwards CA, Hendershot LM, Kaufman RJ. 1997. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J. Biol. Chem. 272:4327-34
38. Ma Y, Hendershot LM. 2001. The unfolding tale of the unfolded protein response. Cell 107:827-30
39. Hendershot L, Wei JY, Gaut J, Melnick J, Aviel S, Argon Y. 1996. Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants. Proc. Natl. Acad. Sci. USA 93:5269-74
40. Melnick J, Dul JL, Argon Y. 1994. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature 370:373-75
41. Reddy P, Sparvoli A, Fagioli C, Fassina G, Sitia R. 1996. Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig light chains. EMBO J. 15:2077-85
42. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415:92-96
43. Sanderson RD, Lalor P, Bernfield M. 1989. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1:27-35
44. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R, Gaidano G. 2001. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97:744-51
45. Drew M, Barker HF, Ball J, Pearson C, Cook G, Franklin I. 1996. Very late antigen (VLA) expression by normal and neoplastic human plasma cells; including an assessment of antibodies submitted to the Vth International Workshop on Leucocyte Differentiation Antigens using human myeloma cell lines. Leuk. Res. 20:619-24
46. Oliver AM, Martin F, Kearney JF. 1997. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J. Immunol. 158:1108-15
47. Deaglio S, Mehta K, Malavasi F. 2001. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk. Res. 25:1-12
48. Silacci P, Mottet A, Steimle V, Reith W, Mach B. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329-36
49. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G,. Zou YR, Littman DR, Cyster JG. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56
50. Garcia De Vinuesa C, Gulbranson-Judge A, Khan M, O'Leary P, Cascalho M, Wabl M, Klaus GG, Owen MJ, MacLennan LC. 1999. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29:3712-21
51. Hao Z, Rajewsky K. 2001. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194:1151-64
52. Berland R, Wortis HH. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253-300
53. Su I, Tarakhovsky A. 2000. B-1 cells: orthodox or conformist? Curr. Opin. Immunol. 12:191-94
54. Hayakawa K, Hardy R. 2000. Development and function of B-1 cells. Curr. Opin. Immunol. 12:346-53
55. Stall AM, Wells SM, Lam KP. 1996. B-1 cells: unique origins and functions. Semin. Immunol. 8:45-59
56. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222-26
57. Lam KP, Stall AM. 1994. Major histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny. J. Exp. Med. 180:507-16
58. Lam KP, Rajewsky K. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190:471-77
59. Fagarasan S, Watanabe N, Honjo T. 2000. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176:205-15
60. Herzenberg LA, Baumgarth N, Wilshire JA. 2000. B-1 cell origins and VH repertoire determination. Curr. Top. Microbiol. Immunol. 252:3-13
61. high splenic B cells enriched in the marginal zone: distinct phenotypes and functions. Curr. Top. Microbiol. Immunol. 246:45-50
62. Cariappa A, Pillai S. 2002. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14:241-49
63. Martin F, Kearney JF. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175:70-79
64. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney IF. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366-74
65. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:7198-7207
66. McHeyzer-Williams LJ, Driver DJ, McHeyzer-Williams MG. 2001. Germinal center reaction. Curr. Opin. Hematol. 8:52-59
67. O'Connor BP, Cascalho M, Noelle RJ. 2002. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J. Exp. Med. 195:737-45
68. Slifka MK, Matloubian M, Ahmed R. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-1902
69. Slifka MK, Ahmed R. 1998. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10:252-58
70. Manz RA, Thiel A, Radbruch A. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133-34
71. Maruyama M, Lam KP, Rajewsky K. 2000. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407:636-42
72. McHeyzer-Williams MG, Ahmed R. 1999. B cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 11:172-79
73. Driver DJ, McHeyzer-Williams LJ, Cool M, Stetson DB, McHeyzer-Williams MG. 2001. Development and maintenance of a B220-memory B cell compartment. J. Immunol. 167:1393-405
74. Lam KP, Kuhn R, Rajewsky K. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073-83
75. Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K, Pillai S. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603-15
76. Waldschmidt TJ, Noelle RJ. 2001. Immunology. Long live the mature B cell-a baffling mystery resolved. Science 293:2012-13
77. Wang H, Marsters SA, Baker T, Chan B, Lee WP, Fu L, Tumas D, Yan M, Dixit VM, Ashkenazi A, Grewal IS. 2001. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2:632-37
78. Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, McCabe S, Qiu WR, Kornuc M, Xia XZ, Guo J, Stolina M, Boyle WJ, Sarosi I, Hsu H, Senaldi G, Theill LE. 2000. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1:252-56
79. Do R, Chen-Kiang S. 2001. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 199:1-8
80. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing D, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108-11
81. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. 2000. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat. Immunol. 1:37-41
82. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-14
83. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15:289-302
84. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, Pacini R, Alunni C, Natali-Tanci L, Ugolini B, Sebastiani C, Cattoretti G, Pileri S, Dalla-Favera R, Stein H. 2000. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95:2084-92
85. Shih TA, Meffre E, Roederer M, Nussenzweig MC. 2002. Role of BCR affinity in T cell dependent antibody responses in vivo. Nat. Immunol. 3:570-75
86. Smith KG, Light A, Nossal GJ, Tarlinton DM. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16:2996-3006
87. Smith KG, Light A, O'Reilly LA, Ang SM, Strasser A, Tarlinton D. 2000. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J. Exp. Med. 191:475-84
88. Stuber E, Strober W. 1996. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979-89
89. Agematsu K, Hokibara S, Nagumo H, Shinozaki K, Yamada S, Komiyama A. 1999. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leukoc. Lymphoma 35:219-25
90. Jacquot S. 2000. CD27/CD70 interactions regulate T dependent B cell differentiation. Immunol. Res. 21:23-30
91. Raman VS, Bal V, Rath S, George A. 2000. Ligation of CD27 on murine B cells responding to T-dependent and T-independent stimuli inhibits the generation of plasma cells. J. Immunol. 165:6809-15
92. Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, Briere F, Banchereau J, Liu YJ. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720-22
93. Choe J, Choi YS. 1998. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol. 28:508-15
94. Jung J, Choe J, Li L, Choi YS. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437-43
95. Zhang X, Li L, Jung J, Xiang S, Hollmann C, Choi YS. 2001. The distinct roles of T cell-derived cytokines and a novel follicular dendritic cell-signaling molecule 8D6 in germinal center-B cell differentiation. J. Immunol. 167:49-56
96. Arpin C, Banchereau J, Liu YJ. 1997. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J. Exp. Med. 186:931-40
97. Silvy A, Lagresle C, Bella C, Defrance T. 1996. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur. J. Immunol. 26:517-24
98. Martin SW, Goodnow CC. 2002. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat. Immunol. 3:182-88
99. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-92
100. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R. 1997. The BCL-6 protooncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-70
101. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N, Tokuhisa T 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186:439-48
102. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood 86:45-53
103. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kerry MR, Staudt LM. 1996. BCL-6 expression during B-cell activation. Blood 87:5257-68
104. Niu H, Ye BH, Dalla-Favera R. 1998. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12:1953-61
105. Kikuchi M, Miki T, Kumagai T, Fukuda T, Kamiyama R, Miyasaka N, Hirosawa S. 2000. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene. Oncogene 19:4941-45
106. de Vinuesa CG, Cook MC, Ball J, Drew M, Sunners Y, Cascalho, Wabl M, Klaus GG, MacLennan IC. 2000. Germinal centers without T cells. J. Exp. Med. 191:485-94
107. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212
108. Turner CA Jr, Mack DH, Davis MM. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297-306
109. Reljic R, Wagner SD, Peakman LJ, Fearon DT 2000. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192:1841-48
110. Nutt SL, Heavey B, Rolink AG, Busslinger M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-62
111. Horcher M, Souabni A, Busslinger M. 2001. Pax5/bsap maintains the identity of B cells in late B lymphopoiesis. Immunity 14:779-90
112. Usui T, Wakatsuki Y, Matsunaga Y, Kaneko S, Kosekc H, Kita T. 1997. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J. Immunol. 158:3197-204
113. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. 2002. Blimp-1-dependent repression of pax-5 is required for differentiation of B cells to immunoglobulin m-secreting plasma cells. Mol. Cell. Biol. 22:4771-80
114. Morrison AM, Nutt SL, Thevenin C, Rolink A, Busslinger M. 1998. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. Semin. Immunol. 10:133-42
115. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-72
116. Neurath MF, Strober W, Wakatsuki Y. 1994. The murine Ig 3′ alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). J. Immunol. 153:730-42
117. Rinkenberger JL, Wallin JJ, Johnson KW, Koshland ME. 1996. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5:377-86
118. Reimold AM, Ponath PD, Li YS, Hardy RR, David CS, Strominger JL, Glimcher LH. 1996. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183:393-401
119. Ma C, Staudt LM. 2001. Molecular definition of the germinal centre stage of B-cell differentiation. Philos. Trans. R. Soc. London Ser. B 356:83-89
120. Wallin JJ, Gackstetter ER, Koshland ME. 1998. Dependence of BSAP repressor and activator functions on BSAP concentration. Science 279:1961-64
121. Wallin JJ, Rinkenberger JL, Rao S, Gackstetter ER, Koshland ME, Zwollo P. 1999. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J. Biol. Chem. 274:15959-65
122. Singh M, Birshtein BK. 1993. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol. Cell. Biol. 13:3611-22
123. Liu XD, Prabhu A, Van Ness B. 1999. Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3′ enhancer that affect synergy with the intron enhancer. J. Biol. Chem. 274:3285-93
124. Shaffer AL, Peng A, Schlissel MS. 1997. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation. Immunity 6:131-43
125. Roque MC, Smith PA, Blasquez VC. 1996. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3′ enhancer. Mol. Cell. Biol. 16:3138-55
126. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-63
127. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan L, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565-75
128. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-11
129. Lai CF, Ripperger J, Morella KK, Jurlander J, Hawley TS, Carson WE, Kordula T, Caligiuri MA, Hawley RG, Fey GH, Baumann H. 1996. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J. Biol. Chem. 271:13,968-75
130. Dal Porto JM, Haberman AM, Kelsoe G, Shlomchik MJ. 2002. Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J. Exp. Med. 195:1215-21
131. Knodel M, Kuss AW, Berberich L, Schimpl A. 2001. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur. J. Immunol. 31:1972-80
132. Schroder AJ, Pavlidis P, Arimura A, Capece D, Rothman P. 2002. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4 stimulated B lymphocytes. J. Immunol. 168:4277-81
133. Choe J, Kim HS, Armitage RJ, Choi YS. 1997. The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. J. Immunol. 159:3757-66
134. Tarlinton DM, Smith KG. 2000. Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol. Today 21:436-41
135. Tridandapani S, Chacko GW, Van Brocklyn JR, Coggeshall KM. 1997. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. J. Immunol. 158:1125-32
136. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412:300-7
137. Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ, Glimcher LH. 2000. An essential role in liver development for transcription factor XBP-1. Genes Dev. 14:152-57
138. Wen X, Stewart AK, Sooknanan RR, Henderson G, Hawley TS, Reimold AM, Glimcher LH, Baumann H, Malek LT, Hawley RG. 1999. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int. J. Oncol. 15:173-78
139. Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M, Mori K. 2000. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 20:6755-67
140. Shen X, Ellis RE, Lee K, Liu CY, Yang K, Solomon A, Yoshida H, Morimoto R, Kurnit DM, Mori K, Kaufman RJ. 2001. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107:893-903
141. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-91
142. Lin K-I, Angelin-Duclos C, Kuo T, Calame K. 2002. Blimp-1-dependent repression of Pax5 is required for differentiation of B cells to IgM-secreting plasma cells. Mol. Cell. Biol. 22:4771-80
143. Keller AD, Maniatis T. 1992. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding. Mol. Cell. Biol. 12:1940-49
144. Ren B, Chee KJ, Kim TH, Maniatis T. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13:125-37
145. Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592-603
146. Schliephake DE, Schimpl A. 1996. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab′)2-co-stimulated B lymphocytes. Eur. J. Immunol. 26:268-71
147. Piskurich JF, Lin KI, Lin Y, Wang Y, Ting JP, Calame K. 2000. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:526-32
148. Messika EJ, Lu PS, Sung YJ, Yao T, Chi JT, Chien YH, Davis MM. 1998. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J. Exp. Med. 188:515-25
149. Kakkis E, Riggs KJ, Gillespie W, Calame K. 1989. A transcriptional repressor of c-myc. Nature 339:718-21
150. Steimle V, Otten LA, Zufferey M, Mach B. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-46
151. Chang CH, Flavell RA. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-67
152. Latron F, Jotterand-Bellomo M, Maffei A, Scarpellino L, Bernard M, Strominger JL, Accolla RS. 1988. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc. Natl. Acad. Sci. USA 85:2229-33
153. Mikkola I, Heavey B, Horcher M, Bus-slinger M. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science 297:110-13
154. Nutt SL, Eberhard D, Horcher M, Rolink AG, Busslinger M. 2001. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int. Rev. Immunol. 20:65-82
155. Wakatsuki Y, Neurath MF, Max EE, Strober W. 1994. The B cell-specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179:1099-108
156. Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y. 1999. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19:5969-80
157. Su GH, Chen HM, Muthusamy N, Garrett-Sinha LA, Baunoch D, Tenen DG, Simon MC. 1997. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16:7118-29
158. Garrett-Sinha LA, Dahl R, Rao S, Barton KP, Simon MC. 2001. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood 97:2908-12
159. Katsuta H, Tsuji S, Niho Y, Kurosaki T, Kitamura D. 1998. Lyn-mediated down-regulation of B cell antigen receptor signaling: inhibition of protein kinase C activation by Lyn in a kinase-independent fashion. J. Immunol. 160:1547-51
160. Kurosaki T, Tsukada S. 2000. BLNK: connecting Syk and Btk to calcium signals. Immunity 12:1-5
161. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A. 1996. Immunodeficiency in protein kinase cbeta-deficient mice. Science 273:788-91
162. Ohya K, Kajigaya S, Kitanaka A, Yoshida K, Miyazato A, Yamashita Y, Yamanaka T, Ikeda U, Shimada K, Ozawa K, Mano H. 1999. Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase. Proc. Natl. Acad. Sci. USA 96:11976-81
163. Reth M, Wienands J. 1997. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15:453-79
164. Matsuyama T, Grossman A, Mittrucker HW, Siderovski DP, Kiefer F, Kawakami T, Richardson CD, Taniguchi T, Yoshinaga SK, Mak TW. 1995. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:2127-36
165. Marecki S, Fenton MJ. 2002. The role of IRF-4 in transcriptional regulation. J. Interferon Cytokine Res. 22:121-33
166. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275:540-43
167. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Kikuchi M, Komatsu H, Banno S, Wakita A, Nakamura S, Eimoto T, Ueda R. 2000. MUM 1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 14:449-56
168. Gupta S, Jiang M, Anthony A, Pernis AB. 1999. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190:1837-48
169. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16:1283-94
170. Eisenbeis CF, Singh H, Storb U. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377-87
171. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell. Biol. 12:368-78
172. Pongubala JM, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. 1993. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622-25
173. Himmelmann A, Riva A, Wilson GL, Lucas BP, Thevenin C, Kehrl JH. 1997. PU. 1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood 90:3984-95
174. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, Beutler B. 2000. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275:9773-81
175. Marecki S, Riendeau CJ, Liang MD, Fenton MJ. 2001. PU.1 and multiple ifn regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1beta gene. J. Immunol. 166:6829-38
176. Gupta S, Anthony A, Pernis AB. 2001. Stage-specific modulation of IFN-regulatory factor 4 function by kruppel-type zinc finger proteins. J. Immunol. 166:6104-11
177. Rao A, Luo C, Hogan PG. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-47
178. Venkataraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R. 1994. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1:189-96
179. Macian F, Lopez-Rodriguez C, Rao A. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20:2476-89
180. Crabtree GR, Olson EN. 2002. NFAT signaling: choreographing the social lives of cells. Cell 109(Suppl.):S67-79
181. Peng SL, Gerth AJ, Ranger AM, Glimcher LH. 2001. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14:13-20
182. Ranger AM, Oukka M, Rengarajan J, Glimcher LH. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627-35
183. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195:1003-12
184. Parslow TG, Blair DL, Murphy WJ, Granner DK. 1984. Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650-54
185. Eaton S, Calame K. 1987. Multiple DNA sequence elements are necessary for the function of an immunoglobulin heavy chain promoter. Proc. Natl. Acad. Sci. USA 84:7634-38
186. Staudt LM, Clerc RG, Singh H, LeBowitz JH, Sharp PA, Baltimore D. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241:577-80
187. Malone CS, Wall R. 2002. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters. J. Immunol. 168:3369-75
188. Malone CS, Patrone L, Buchanan KL, Webb CF, Wall R. 2000. An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression. J. Immunol. 164:2550-56
189. Malone CS, Patrone L, Wall R. 2000. An essential octamer motif in the mb-1 (Igalpha) promoter. Mol. Immunol. 37:321-28
190. Matthias P. 1998. Lymphoid-specific transcription mediated by the conserved octamer site: Who is doing what? Semin. Immunol. 10:155-63
191. Corcoran LM, Karvelas M, Nossal GJ, Ye ZS, Jacks T, Baltimore D. 1993. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:570-82
192. Shah PC, Bertolino E, Singh H. 1997. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J. 16:7105-1
193. Nielsen PJ, Georgiev O, Lorenz B, Schaffner W. 1996. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26:3214-18
194. Qin XF, Reichlin A, Luo Y, Roeder RG, Nussenzweig MC. 1998. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 17:5066-75
195. Schubart K, Massa S, Schubart D, Corcoran LM, Rolink AG, Matthias P. 2001. B cell development and immunoglobulingene transcription in the absence of Oct-2 and OBF-1. Nat. Immunol. 2:69-74
196. Wolf I, Pevzner V, Kaiser E, Bernhardt G, Claudio E, Siebenlist U, Forster R, Lipp M. 1998. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF- kappaB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 273:28831-36
197. Wehrli N, Legler DF, Finke D, Toellner KM, Loetscher P, Baggiolini M, MacLennan IC, Acha-Orbea H. 2001. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur. J. Immunol. 31:609-16
198. Tourigny MR, Ursini-Siegel J, Lee H, Toellner KM, Cunningham AF, Franklin DS, Ely S, Chen M, Qin XF, Xiong Y, MacLennan IC, Chen-Kiang S. 2002. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity 17:179-89